Skip to main content

New from Alpha BoardBrief: The Adolescence of Governance · Read the doctrineAlpha BoardBrief: The Adolescence of Governance · Read the doctrine

Learn More about Alpha institutional services Appearance

Research Policy & Standards Education Events Alpha BoardBrief

Talk to the Institute

Platform Institute Council Events Company Registry Evals Research Policy & Standards Education Events Alpha BoardBrief

Back to Executive Profile

Alpha Profiles · Executive Profile

Chris Cabell, M.D.

Director at Inhibikase Therapeutics, Inc. (NASDAQ: IKT)

https://registry.alpha.ac/people/chris-cabell-m-d

CC

Record status

Verified facts: 13
Profile ownership: Pending
Verified record version: v0
Presentation version: Alpha editorial

Owner-supplied résumé and presentation fields remain distinct from independently verified Alpha Profile facts.

Generated 2026-10-17T01:55:09.391Z

Data as of 2026-10-17T01:55:09.064708+00:00

https://registry.alpha.ac/people/chris-cabell-m-d

The Alpha Institute for AI Governance is the research, policy, standards, education and convening arm of Alpha Governance PBC.

Institute

Research Policy & Standards Education Events Alpha Council About

Alpha ecosystem

Alpha Governance PBC Alpha Evals Alpha Intelligence Alpha Governance Registry Council member portal

Access

Alpha BoardBrief Education inquiry Partnership inquiry Privacy Terms

© 2026 Alpha Governance PBCGovernance is Alpha.Appearance